Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 373 Neoplasms 323 Neoplasm Metastasis 286 Leukemia, Myeloid, Acute 277 Breast Neoplasms 271 Colorectal Neoplasms 238 Melanoma 193 Ovarian Neoplasms 191 Recurrence 183 Multiple Myeloma 178 Prostatic Neoplasms 156 Lung Neoplasms 156 Pancreatic Neoplasms 152 Squamous Cell Carcinoma of Head and Neck 150 Lymphoma, Non-Hodgkin 146 Glioblastoma 145 Triple Negative Breast Neoplasms 119 Myelodysplastic Syndromes 114 Carcinoma, Renal Cell 111 Stomach Neoplasms 110 Glioma 108 Brain Neoplasms 105 Advanced Solid Tumors 104 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Lymphoma, Large B-Cell, Diffuse 101 Lymphoma 100 Lymphoma, B-Cell 97 Carcinoma, Hepatocellular 95 Endometrial Neoplasms 92 Lymphoma, Follicular 91

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × HER2 Positive Breast Cancer × 1 year × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡